Literature DB >> 8298382

Fever, vasculitic rash, arthritis, pericarditis, and pericardial effusion after mesalazine.

A G Lim1, K R Hine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8298382      PMCID： PMC2539213          DOI： 10.1136/bmj.308.6921.113

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Mesalazine induced lupus-like syndrome.

Authors:  M T Pent; S Ganapathy; C D Holdsworth; K C Channer
Journal:  BMJ       Date:  1992-07-18

2.  Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease.

Authors:  H Jenss; E W Becker; P Weber
Journal:  Am J Gastroenterol       Date:  1990-03       Impact factor: 10.864

3.  Kawasaki-like syndrome after treatment with mesalazine.

Authors:  H Waanders; J Thompson
Journal:  Am J Gastroenterol       Date:  1991-02       Impact factor: 10.864
  3 in total
  5 in total

1.  A large chronic pericardial effusion in an ultramarathon runner with anti-CCP positive rheumatoid arthritis.

Authors:  Thomas J McClelland; Rose Penfold; Stefan Kluzek; Navraj S Nagra
Journal:  BMJ Case Rep       Date:  2017-06-13

2.  Mesalazine toxicity.

Authors:  D Honeybourne
Journal:  BMJ       Date:  1994-02-19

Review 3.  5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2016-12-23

Review 4.  Acetaminophen poisoning-induced heart injury: a case-based review.

Authors:  Fatemeh KhabazianZadeh; Tooba Kazemi; Samaneh Nakhaee; Patrick C Ng; Omid Mehrpour
Journal:  Daru       Date:  2019-11-11       Impact factor: 3.117

5.  5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis.

Authors:  Jun Miyoshi; Katsuyoshi Matsuoka; Atsushi Yoshida; Makoto Naganuma; Tadakazu Hisamatsu; Tomoharu Yajima; Nagamu Inoue; Susumu Okamoto; Yasushi Iwao; Haruhiko Ogata; Fumiaki Ueno; Toshifumi Hibi; Takanori Kanai
Journal:  Intest Res       Date:  2018-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.